Geneos Wealth Management’s AvePoint AVPT Stock Holding History

Geneos Wealth Management’s Portfolio AVPT Stock Details AVPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-80	Closed	-$634	–	2066
2024 Q1	$634	Buy	+80	New	+$629	﹤0.01%	2102

Other funds holding AVPT

Anchor IV Singapore $196M AUM 75.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geneos Wealth Management's AVPT Position: Q2 2024 in Review

Geneos Wealth Management sold out of AvePoint (AVPT) in Q2 2024, closing a stake of 80 shares — an estimated $634 sold.

Geneos Wealth Management first reported a position in AVPT in Q1 2024 and held it in 1 quarter. The position peaked at $634 in Q1 2024. 175 funds tracked by Wall St. Rank hold AVPT as of Q2 2024.

Geneos Wealth Management reported no remaining AvePoint position as of Q2 2024 after selling out during the quarter.
Geneos Wealth Management sold 80 AvePoint shares in Q2 2024, an estimated $634.
Geneos Wealth Management first reported a position in AvePoint in Q1 2024 and held it in 1 quarter.
Geneos Wealth Management's AvePoint position peaked at $634 in Q1 2024.
175 funds tracked by Wall St. Rank held AvePoint as of Q2 2024.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.